SCHEMBL22799086

SCHEMBL22799086

CC1OCC2(CCN(C(=O)O)CC2)C1C

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.35
▸ PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21631637 0.85 NAMPT (0.34) NAMPTPTPN11
SCHEMBL16914259 0.85 NAMPT (0.34) NAMPTPTPN11
SCHEMBL24097996 0.76 — —
SCHEMBL30296041 0.72 — —
SCHEMBL20571857 0.72 — —
SCHEMBL22798668 0.72 — —
SCHEMBL20571856 0.72 — —
SCHEMBL22799054 0.72 — —
SCHEMBL16914263 0.70 NAMPT (0.33) NAMPT
SCHEMBL18321919 0.69 USP2 (0.34) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753941-A1 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Blueray Biopharma Co., Ltd. (CN) 2020-12-23 — — EP disclosed
Send feedback